Meenal Gauri Appointed MD Boehringer Ingelheim India
Analysis based on 7 articles · First reported Feb 24, 2026 · Last updated Feb 27, 2026
The appointment of Meenal Gauri as Managing Director for Boehringer Ingelheim's India operations is expected to positively impact the company's growth trajectory in the region. This strategic leadership change signals a commitment to innovation and market expansion in India and neighboring countries, potentially leading to increased market share and patient impact for Boehringer Ingelheim.
Boehringer Ingelheim has announced the appointment of Meenal Gauri as the Managing Director for its India operations, effective January 12, 2026. In this role, Meenal Gauri will oversee the company's businesses in India, Bangladesh, Nepal, Sri Lanka, and the Maldives, and will also join the Board of Boehringer Ingelheim India. With over 16 years of international experience in marketing, sales, corporate strategy, business development, and market access within the healthcare sector, Meenal Gauri is expected to lead Boehringer Ingelheim India in achieving its ambitious India Vision 2030. Evren Ozlu, Head of Human Pharma for the IMETA region, expressed confidence in her leadership to drive innovation, strengthen partnerships, and make a positive impact on patients and communities.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard